XML 25 R8.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Cash Flows
$ in Millions
 12 Months Ended
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Operating activities:      
Net income (loss) $ (615) $ (2,499) $ 456
Adjustments to reconcile net income (loss) to net cash provided by operations:      
Impairment of goodwill, long-lived assets and assets held for sale 1,078 2,447 584
Depreciation and amortization 1,153 1,308 1,330
Net change in operating assets and liabilities (72) 1,355 (1,701)
Deferred income taxes — net and uncertain tax positions (317) (1,064) (120)
Stock-based compensation 121 124 119
Research and development in process 0 0 10
Net loss (gain) from investments and from sale of business and long-lived assets (41) 10 104
Other items 61 (91) 16
Net cash provided by (used in) operating activities 1,368 1,590 798
Investing activities:      
Beneficial interest collected in exchange for securitized trade receivables 1,477 1,140 1,648
Purchases of property, plant and equipment and intangible assets (526) (548) (562)
Proceeds from sale of business and long-lived assets 68 68 311
Purchases of investments and other assets (46) (1) (47)
Proceeds from sale of investments 0 4 172
Acquisitions of businesses, net of cash acquired 0 (7) 0
Other investing activities (5) 0 1
Net cash provided by (used in) investing activities 968 656 1,523
Financing activities:      
Repayment of senior notes and loans and other long term liabilities (4,152) (1,369) (6,649)
Proceeds from senior notes, net of issuance costs 2,451 0 4,974
Proceeds from short term debt 700 0 700
Repayment of short term debt (700) 0 (700)
Redemption of convertible debentures 0 0 (491)
Other financing activities (212) (118) (6)
Net cash provided by (used in) financing activities (1,913) (1,487) (2,172)
Translation adjustment on cash and cash equivalents (30) (123) (128)
Net change in cash, cash equivalents and restricted cash 393 636 21
Balance of cash, cash equivalents and restricted cash at beginning of year 2,834 2,198 2,177
Balance of cash, cash equivalents and restricted cash at end of year 3,227 2,834 2,198
Reconciliation of cash, cash equivalents and restricted cash reported in the consolidated balance sheets:      
Cash and cash equivalents 3,226 2,801 2,165
Restricted cash included in other current assets 1 33 33
Total cash, cash equivalents and restricted cash shown in the statement of cash flows 3,227 2,834 2,198
Non-cash financing and investing activities:      
Beneficial interest obtained in exchange for securitized trade receivables 1,446 1,189 1,635
Dividend declared to non-controlling interests 67 0 0
Cash paid during the year for:      
Interest 1,078 948 913
Income taxes, net of refunds 298 543 495
Net change in operating assets and liabilities:      
Other current assets (1,525) (828) (2,271)
Trade payables, accrued expenses, employee-related obligations and other liabilities 1,588 2,012 764
Trade receivables net of sales reserves and allowances 12 334 (574)
Inventories (147) (163) 380
Net Change In Items Comprising Supplemental Disclosure Of Cash Flow Information $ (72) $ 1,355 $ (1,701)